Results 41 to 50 of about 854,762 (292)

Enhancing Security on Touch-Screen Sensors with Augmented Handwritten Signatures

Sensors, 2020
We aim at enhancing personal identity security on mobile touch-screen sensors by augmenting handwritten signatures with specific additional information at the enrollment phase.
Majd Abazid, Nesma Houmani, Sonia Garcia-Salicetti   +2 more
doaj   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger   +10 more
wiley   +1 more source

Verification of DNSsec Delegation Signatures [PDF]

2014 21st International Conference on Telecommunications (ICT), 2014
In this paper, we present a formal model for the verification of the DNSsec Protocol in the interactive theorem prover Isabelle/HOL. Relying on the inductive approach to security protocol verification, this formal analysis provides a more expressive representation than the widely accepted model checking analysis.
openaire   +2 more sources

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

SVC-onGoing: Signature verification competition

Pattern Recognition, 2022
This article presents SVC-onGoing, an on-going competition for on-line signature verification where researchers can easily benchmark their systems against the state of the art in an open common platform using large-scale public databases, such as DeepSignDB and SVC2021_EvalDB, and standard experimental protocols.
Ruben Tolosana, Rubén Vera-Rodríguez, Carlos Gonzalez-Garcia, Julian Fiérrez, Aythami Morales, Javier Ortega-Garcia, Juan-Carlos Ruiz-Garcia 0002, Sergio Romero-Tapiador, Santiago Rengifo, Miguel Caruana, Jiajia Jiang, Songxuan Lai, Lianwen Jin, Yecheng Zhu, Javier Galbally, Moisés Díaz, Miguel Ángel Ferrer, Marta Gomez-Barrero, Ilya A. Hodashinsky, Konstantin S. Sarin, Artem Slezkin, Marina Bardamova, Mikhail Svetlakov, Mohammad Saleem 0001, Cintia Lia Szücs, Bence Kovári, Falk Pulsmeyer, Mohamad Wehbi, Dario Zanca, Sumaiya Ahmad, Sarthak Mishra, Suraiya Jabin   +31 more
openaire   +5 more sources

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak, Katarzyna Bilska, Tomasz Koziński, Jadwiga Węcławek‐Tompol, Dorota Sega‐Pondel, Radosław Chaber, Wanda Badowska, Katarzyna Rosłan, Hanna Koseła‐Paterczyk, Anna Raciborska   +9 more
wiley   +1 more source

Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi, Rie Tanaka, Reona Kawahira, Shingo Nabeta, Kouhei Naoi, Kazuhito Kitajima, Akira Wada, Tomonari Takagi, Norihiko Ohura, Akira Miyamoto   +9 more
wiley   +1 more source

Effectiveness of Resistance Intradialytic Exercise Compared to Aerobic Intradialytic Exercise for Patients With Chronic Kidney Disease: A Randomized Controlled Clinical Trial

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Patients with chronic kidney disease undergoing hemodialysis commonly experience reduced physical function, fatigue, poor sleep quality, and impaired health‐related quality of life. Intradialytic exercise has been proposed as a non‐pharmacological strategy to improve these outcomes.
Klebson da Silva Almeida, Gisela Cristiane Miyamoto, Daniel da Costa Torres, Ian Setubal Reis Chaves, Jonas do Carmo Paschoalin, Braúlio Lima Nascimento, Luciana Dias Chiavegato   +6 more
wiley   +1 more source

Automated Offline Arabic Signature Verification System using Multiple Features Fusion for Forensic Applications

Arab Journal of Forensic Sciences & Forensic Medicine, 2016
The signature of a person is one of the most popular and legally accepted behavioral biometrics that provides a secure means for verification and personal identification in many applications such as financial, commercial and legal transactions.
Saad M. Darwish, Ashraf M. El-Nour
doaj   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa, Kyomi Kanaya, Kiyomi Aizawa, Masanori Onoki, Hirofumi Ozeki, Kazuko Suzuki, Ai Hayashi, Tomohiko Asamura   +7 more
wiley   +1 more source